CRIS Current Research Information System

POPPI, LAURA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.608
EU - Europa 1.011
NA - Nord America 957
SA - Sud America 82
Continente sconosciuto - Info sul continente non disponibili 57
AF - Africa 54
OC - Oceania 2
Totale 3.771
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 893
IT - Italia 605
CN - Cina 437
SG - Singapore 382
VN - Vietnam 359
HK - Hong Kong 96
KR - Corea 86
IN - India 85
BR - Brasile 67
DE - Germania 63
GB - Regno Unito 62
FR - Francia 43
JP - Giappone 42
NL - Olanda 41
IE - Irlanda 40
CA - Canada 33
SE - Svezia 25
CI - Costa d'Avorio 20
BD - Bangladesh 19
FI - Finlandia 19
PH - Filippine 19
DK - Danimarca 18
ES - Italia 18
TW - Taiwan 17
CH - Svizzera 16
AT - Austria 12
IR - Iran 12
RU - Federazione Russa 12
TR - Turchia 12
MX - Messico 11
EG - Egitto 10
CZ - Repubblica Ceca 6
JO - Giordania 6
PL - Polonia 6
TH - Thailandia 6
BG - Bulgaria 5
ID - Indonesia 5
IQ - Iraq 5
MA - Marocco 5
ZA - Sudafrica 5
AE - Emirati Arabi Uniti 4
BE - Belgio 4
CR - Costa Rica 4
JM - Giamaica 4
AR - Argentina 3
DZ - Algeria 3
GR - Grecia 3
HN - Honduras 3
LT - Lituania 3
MM - Myanmar 3
PK - Pakistan 3
PY - Paraguay 3
SA - Arabia Saudita 3
SC - Seychelles 3
TG - Togo 3
AU - Australia 2
EC - Ecuador 2
GF - Guiana Francese 2
GT - Guatemala 2
MQ - Martinica 2
MY - Malesia 2
NG - Nigeria 2
NI - Nicaragua 2
RO - Romania 2
SI - Slovenia 2
TT - Trinidad e Tobago 2
UA - Ucraina 2
AZ - Azerbaigian 1
CL - Cile 1
CO - Colombia 1
GD - Grenada 1
GE - Georgia 1
GH - Ghana 1
HR - Croazia 1
HU - Ungheria 1
MW - Malawi 1
OM - Oman 1
PE - Perù 1
PT - Portogallo 1
SM - San Marino 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
UY - Uruguay 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 3.714
Salva come PNG Salva come JPEG
Città #
Singapore 307
Hefei 167
Bologna 166
Ashburn 112
Ho Chi Minh City 104
Hanoi 92
San Jose 85
Hong Kong 79
Seoul 69
Los Angeles 49
Milan 49
Dallas 44
Santa Clara 40
Dublin 38
Council Bluffs 36
Beijing 35
Tokyo 34
Genoa 28
Bengaluru 26
Rome 25
Abidjan 20
Da Nang 20
New York 19
Chandler 18
São Paulo 18
Copenhagen 16
Lauterbourg 16
Florence 15
Frankfurt am Main 15
Boardman 14
Phoenix 14
Atlanta 13
Hyderabad 13
Rimini 13
Helsinki 12
Modena 12
Amsterdam 11
Falkenstein 11
Montreal 11
Stockholm 11
Vienna 11
Chicago 10
Forlì 10
London 10
Munich 10
Nanjing 10
Philadelphia 10
Denver 9
Naples 9
Seattle 9
Baltimore 8
Calcinelli 8
Haiphong 8
Nerviano 8
Redondo Beach 8
Shanghai 8
Biên Hòa 7
Buffalo 7
Cambridge 7
Düsseldorf 7
Exeter 7
Hải Dương 7
Prato 7
Toronto 7
Turin 7
Verona 7
Zurich 7
Barcelona 6
Boston 6
Brooklyn 6
Carlsbad 6
Cento 6
Claymont 6
Fano 6
Laurel 6
Paris 6
Poplar 6
Québec 6
Amman 5
Cairo 5
Las Vegas 5
Mexico City 5
Minneapolis 5
New Taipei City 5
Parma 5
Perugia 5
Reggio Emilia 5
Sofia 5
Southend 5
Tianjin 5
Wanchai 5
Birmingham 4
Bắc Ninh 4
Can Tho 4
Carpi 4
Chandigarh 4
Chantilly 4
Chennai 4
Hamburg 4
Imola 4
Totale 2.267
Salva come PNG Salva come JPEG
Nome #
A RAD51/BRCA2 small molecule inhibitor enhances the antineoplastic effect of the PARPi talazoparib in pancreatic cancer 372
A journey through targeting BRCA2-RAD51 protein-protein interaction to establish synthetic lethality as paradigm for anticancer drug discovery 284
Insights into the activity of ARN24089, a new RAD51-BRCA2 disruptor that inhibits homologous recombination and achieves synthetic lethality in pancreatic cancer 277
Investigating synthetic lethality and PARP inhibitor resistance in pancreatic cancer through enantiomer differential activity 261
Identification and subsequent development of RAD51-BRCA2 disruptors through a fragment-based approach 236
Preomic profile of BxPC-3 cells after treatment with BRC4 235
An 19F NMR fragment-based approach for the discovery and development of BRCA2-RAD51 inhibitors to pursuit synthetic lethality in combination with PARP inhibition in pancreatic cancer 219
HIPPO AND NECROPTOSIS PATHWAYS AS POSSIBLE PLAYERS IN THE NEURONOPATHIC GAUCHER 211
Differential enantiomers activity of ARN24089 to achieve synthetic lethality in pancreatic cancer 208
Design and synthesis of RAD51-BRCA2 protein-protein interaction disruptors to trigger synthetic lethality with Olaparib in pancreatic cancer cells 203
Design and synthesis of RAD51-BRCA2 disruptors to inhibit homologous recombination and achieve synthetic lethality in pancreatic cancer cells 196
The Mechanistic Understanding of RAD51 Defibrillation: A Critical Step in BRCA2-Mediated DNA Repair by Homologous Recombination 179
Exploring the Role of TERT in Thyroid Cancer: A Systematic Review 176
Endometrial carcinoma and immune escape: prognostic relevance of HLA class I loss in NSMP subtype 147
Proteomic profile of BxPC-3 cells after treatment with BRC4 142
Targeting RAD51-BRCA2 Interaction to Enhance Synthetic Lethality with Olaparib in Pancreatic Cancer: Development of a Novel Phenyl Furan-Quinoline-Carboxylic Acid Series 126
ESR1 analysis of liquid biopsy in breast cancer, one-year routine experience of an Italian clinical referral center 114
Corrigendum to “Exploring the role of TERT in thyroid cancer: A systematic review” [Crit. Rev. Oncol./Hematol. 213 (2025) 104792] (Critical Reviews in Oncology / Hematology (2025) 213, (S1040842825001805), (10.1016/j.critrevonc.2025.104792)) 104
Somatic genetic alterations in the development and progression in thyroid tumors of follicular cells 81
Totale 3.771
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.019
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.019
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202216 0 0 0 4 1 1 0 0 2 0 4 4
2022/202399 4 6 1 6 25 6 6 1 6 1 4 33
2023/2024346 70 26 10 15 22 15 32 23 7 18 56 52
2024/2025730 52 35 37 19 118 48 62 30 41 57 80 151
2025/20262.185 176 215 177 228 172 83 303 102 335 149 95 150
2026/2027369 110 78 174 7 0 0 0 0 0 0 0 0
Totale 3.771